24hr Imaging Of HCC After EOVIST

• Status: Withdrawn
• Trial end date: 2015-07-01

Summary

In this research study, the investigators are looking to see if MR imaging with Eovist performed 24 hours after the injection of Eovist helps improve the identification and characterization of focal liver tumors.

• Phase: Early Phase 1

Details

• Lead Sponsor: Massachusetts General Hospital